Cutler Group LP Arcturus Therapeutics Holdings Inc. Call Options Transaction History

Cutler Group LP

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 01, 2023	SELL	$14.72 - $23.97 $13,248 - $21,573	-900 Reduced 81.82%	200 $0
Q4 2022 Feb 07, 2023	SELL	$14.14 - $23.06 $1,414 - $2,306	-100 Reduced 8.33%	1,100 $0
Q3 2022 Oct 25, 2022	SELL	$13.05 - $22.13 $52,200 - $88,520	-4,000 Reduced 76.92%	1,200 $0
Q2 2022 Aug 04, 2022	SELL	$12.26 - $31.17 $109,114 - $277,413	-8,900 Reduced 63.12%	5,200 $6,000
Q1 2022 Apr 14, 2022	SELL	$17.64 - $39.57 $45,864 - $102,882	-2,600 Reduced 15.57%	14,100 $21,000
Q4 2021 Jan 18, 2022	BUY	$34.2 - $47.56 $307,800 - $428,040	9,000 Added 116.88%	16,700 $98,000
Q3 2021 Oct 26, 2021	BUY	$27.88 - $58.25 $170,068 - $355,325	6,100 Added 381.25%	7,700 $17,000
Q1 2021 Apr 26, 2021	SELL	$38.75 - $86.92 $259,625 - $582,364	-6,700 Reduced 80.72%	1,600 $1,000
Q4 2020 Jan 21, 2021	BUY	$34.61 - $123.66 $17,305 - $61,830	500 Added 6.41%	8,300 $18,000
Q3 2020 Oct 27, 2020	BUY	$37.49 - $63.19 $183,701 - $309,631	4,900 Added 168.97%	7,800 $87,000
Q2 2020 Jul 22, 2020	BUY	$12.66 - $58.27 $24,054 - $110,713	1,900 Added 190.0%	2,900 $19,000
Q1 2020 May 07, 2020	BUY	$9.31 - $18.26 $9,310 - $18,260	1,000 New	1,000 $0

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $411M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.